All In MedTech

PMA device

AMS Ambicor Inflatable Penile Prosthesis

Boston Scientific Corp · Prosthesis, Penis, Inflatable (JCW, Class III) · First FDA decision Mar 28, 2019, newest Mar 28, 2019Erectile dysfunction

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

PMA pathway

Device trials

2

Naming "AMS Ambicor"

MAUDE reports

988

Brand "AMS Ambicor", since 2015

PubMed studies

9

Mentioning "AMS Ambicor"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing AMS Ambicor Inflatable Penile Prosthesis

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "AMS Ambicor", any status and sponsor, newest update first.

Open in Trial Radar

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "AMS Ambicor", and for the whole product code for context.

This brand

988 reports: 105 malfunction, 883 injury, 0 death

Whole product code JCW

3,286 reports: 191 malfunction, 3,092 injury, 1 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "AMS Ambicor"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code JCW.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.